Evidence map›Paper›PMID 37888090›Full record

ReviewJournal of personalized medicine2023

Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment.

Michael J Diaz, Nicole Natarelli, Aria Wei, Michaela Rechdan, Elizabeth Botto, Jasmine T Tran, Mahtab Forouzandeh, Jose A Plaza, Benjamin H Kaffenberger

Open access · goldAbstract readReview
In one paragraph

Review in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Michael J DiazCollege of Medicine, University of Florida, Gainesville, FL 32610, USA.
Nicole NatarelliMorsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.ORCID 0000-0003-0338-5607
Aria WeiSchool of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Michaela RechdanCollege of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0001-7449-9869
Elizabeth BottoMorsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
Jasmine T TranSchool of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Mahtab ForouzandehDepartment of Dermatology, University of Florida, Gainesville, FL 32606, USA.
Jose A PlazaDepartment of Dermatology, Ohio State University Wexner Medical Center, Columbus, OH 43221, USA.
Benjamin H KaffenbergerDepartment of Dermatology, Ohio State University Wexner Medical Center, Columbus, OH 43221, USA.ORCID 0000-0001-8079-0011
University of Florida · USThe Ohio State University Wexner Medical Center · USUniversity of South Florida · USIndiana University – Purdue University Indianapolis · USThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder characterized by inflammatory arthritis and periarticular structural damage. Available evidence suggests that RA results from complex interactions between genetic susceptibility (e.g., HLA-DRB1), environmental factors (e.g., smoking), and immune dysregulation. Alongside joint-related symptoms, individuals with RA may also experience a wide array of skin issues, including the development of nodules, neutrophilic dermatoses, vasculitis, and vasculopathy. Treatment strategies for these manifestations vary but routinely involve corticosteroids, disease-modifying anti-rheumatic drugs, and biologics, with individualized approaches guided by disease severity. In this review, we provide comprehensive insights into the skin-related issues associated with RA, outlining their clinical characteristics and histopathological findings. Our aim is to facilitate early diagnosis and personalized treatment to improve the quality of life of affected individuals.

Indexed as

cutaneous manifestationshistopathologyneutrophilic dermatosespyoderma gangrenosumquality of liferheumatoid arthritisrheumatoid nodulessweet syndromevasculopathies

Identifiers

PMID37888090
PMCPMC10608460
OpenAlexW4387502109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.